Companies: 48,874 Total Market Cap: 132456628851223.12

Yield10 Bioscience

OTC-YTENQ
Materials Agricultural Inputs
Rank #48522
Market Cap 11,016
Volume 0
Price 0.02
Change (%) 0.00%
Country or region United States United States

Yield10 Bioscience's latest marketcap:

11,016

As of 05/20/2025, Yield10 Bioscience's market capitalization has reached $11,016. According to our data, Yield10 Bioscience is the 48522th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 11,016
Revenue (ttm) 750,000
Net Income (ttm) -12,702,000
Shares Out 734,408
EPS (ttm) -24.93
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date 05/09/2025
Market Cap Chart
Data Updated: 05/20/2025

Yield10 Bioscience's yearly market capitalization.

Yield10 Bioscience has seen its market value drop from $19.27 M to $11,016 since 2020, representing a total decrease of 99.94% and an annual compound decline rate (CAGR) of 81.79%.
Date Market Cap Change (%)
05/20/2025 $11,016 -95.19%
12/31/2024 $229,135 -92.01%
12/29/2023 $2.87 M -65.27%
12/30/2022 $8.25 M -65.63%
12/31/2021 $24.02 M 24.64%
12/31/2020 $19.27 M

Company Profile

About Yield10 Bioscience, Inc.

Yield10 Bioscience, Inc. is an agricultural bioscience company specializing in the commercialization of products derived from Camelina oilseeds. Headquartered in Woburn, Massachusetts, the company focuses on sustainable solutions for food, feed, and biofuel industries.

Key Products

  • Camelina Oil: Engineered to produce high levels of omega-3 fatty acids, including EPA and DHA, for nutritional applications.
  • Biofuel Feedstock: Provides a low-carbon intensity feedstock for biodiesel, renewable diesel (RD), and sustainable aviation fuel (SAF).

Corporate Background

Originally founded as Metabolix, Inc. in 1992, the company rebranded to Yield10 Bioscience, Inc. in January 2017. On December 6, 2024, Yield10 and its affiliates filed for Chapter 11 bankruptcy reorganization in the U.S. Bankruptcy Court for the District of Delaware.

Frequently Asked Questions

As of 05/20/2025, Yield10 Bioscience (including the parent company, if applicable) has an estimated market capitalization of $11,016 USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Yield10 Bioscience global market capitalization ranking is approximately 48522 as of 05/20/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region United States
Founded 1992
IPO Date n/a
Employees 29
CEO Oliver Peoples
Sector Materials
Industry Agricultural Inputs
Address 19 Presidential Way
Woburn, Delaware 01801
United States
Website https://www.yield10bio.com